5:22 PM
Feb 22, 2013
 |  BC Extra  |  Company News

J&J submits simeprevir application in Japan

Medivir AB (SSE:MVIR B) said partner Johnson & Johnson (NYSE:JNJ) submitted a regulatory application to Japan's Ministry of Health,...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >